News
Phase 3 results revealed Monday led shares to surge and should yield an approval application in IgA nephropathy, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback